From the results of the ROC analysis, we determined that serum sIL-2R and plasma CXCL10 had the highest potential for distinguishing HAM/TSP patients from ACs with high sensitivity and specificity (area under the ROC curve [AUC]>0.9), followed by plasma CXCL9 and HTLV-1 proviral load in PBMCs (0.8<AUC<0.9) (Figure 1B). The gene discussed is CXCL10; the disease is tropical spastic paraparesis.